Leucine/sildenafil/metformin companion diagnostic - NuSirt Biopharma/OWL Metabolomics
Latest Information Update: 23 Sep 2016
At a glance
- Originator NuSirt Biopharma
- Developer NuSirt Biopharma; One Way Liver Genomics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Non-alcoholic fatty liver disease